TRANSLATION 2024 aims to reflect on the evolving landscape and transform our ability to carry out research and make vital breakthroughs into one of the world’s most pressing public health challenges.
This year our line-up of speakers is drawn from a broad spectrum of areas across dementia research. It is what makes this conference unusual in drawing both speakers and conference-goers from a wide landscape. Take a look at the speakers on our conference website pages
Biomarkers
Current research studies show that non-invasive, economical and easy to obtain biomarkers offer one of the most promising paths for the diagnosis of dementia. Professor Charlotte Teunissen, Amsterdam UMC will kick off our conference with this hot topic titled “The Biomarker Revolution.”
There are already very promising developments in studying biomarkers and this vital area has seen a surge in interest. We’ll be hearing more from the platform at Translation 2024 from the other session speakers:
Dr. Do Guen Kim , Korea Brain Research Institute; Dr. Nick Ashton, University of Gothenburg; Professor Cornelia van Duijn, University of Oxford
Big Data
Other areas are equally dynamic. For example, the conference will be exploring data-sharing initiatives and practices in dementia research and hearing about the new opportunities and challenges the most important steps should be to move forwards. Discussions about new developments in Big Data and the challenges of working with extremely large datasets will be led by Keynote speaker Professor David Bennett from RUSH University in Chicago. During the second day of the conference, David will be joined by our other speakers to look at datasets and complexity in age-related cognitive decline. Other session speakers include:
Professor Ira Haraldsen, Oslo University Hospital; Dr. Robin Wolz, IXICO
Trials Delivery
The whole dementia research community is also galvanised by the new opportunities to build capacity and scale to advance the search for viable patient therapies. Speaking as a keynote, Dr Hilary Evans of Alzheimer’s Research UK and co-Chair of the Dame Barbara Windsor Dementia Mission will highlight the opportunities new how recent initiatives are going to enable Trials Delivery and many more areas of research and translational medicine. This session will be looking at the remaining barriers to effective trials in dementia research including recruitment into trials. Other speakers in our Trials Delivery session are:
Dr. Lynn Hughes, GAP; Victoria Breeden, Lilly; Professor Robert Perneczky, LMU Hospital, Munich
Our full conference programme aims to align academia and industry and we thank our sponsors for supporting this event.
Translation 2024 will take place in Central London, on Thursday 18th and Friday 19th April at the Congress Centre in Great Russell Street, close to the British Musuem.